Total Payments
$5,454
2023 Payments
$149.46
Companies
39
Transactions
278
Medicare Patients
12
Medicare Billing
$1,272

Payment Breakdown by Category

Food & Beverage$5,255 (96.4%)
Education$198.95 (3.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,255 275 96.4%
Education $198.95 3 3.6%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $591.42 32 $0 (2023)
Merck Sharp & Dohme Corporation $568.31 36 $0 (2019)
AstraZeneca Pharmaceuticals LP $517.78 31 $0 (2019)
Novartis Pharmaceuticals Corporation $460.07 29 $0 (2019)
Amgen Inc. $421.37 13 $0 (2019)
Astellas Pharma US Inc $388.02 14 $0 (2019)
Celgene Corporation $321.98 15 $0 (2019)
PFIZER INC. $268.91 19 $0 (2018)
Seattle Genetics, Inc. $211.71 8 $0 (2018)
Incyte Corporation $211.54 7 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $149.46 1 E.R. Squibb & Sons, L.L.C. ($149.46)
2022 $99.08 1 E.R. Squibb & Sons, L.L.C. ($99.08)
2019 $1,093 58 Merck Sharp & Dohme Corporation ($138.53)
2018 $1,922 109 Merck Sharp & Dohme Corporation ($269.79)
2017 $2,190 109 AstraZeneca Pharmaceuticals LP ($273.45)

All Payment Transactions

278 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
05/24/2023 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $149.46 General
Category: Oncology
05/09/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $99.08 General
12/04/2019 Astellas Pharma US Inc XOSPATA (Drug) Food and Beverage In-kind items and services $19.61 General
Category: ONCOLOGY
10/30/2019 Astellas Pharma US Inc XOSPATA (Drug) Food and Beverage In-kind items and services $21.36 General
Category: ONCOLOGY
10/01/2019 Novartis Pharmaceuticals Corporation PIQRAY (Drug), SANDOSTATIN, VOTRIENT Food and Beverage In-kind items and services $19.56 General
Category: ONCOLOGY
08/20/2019 Janssen Biotech, Inc. Erleada (Drug) Food and Beverage In-kind items and services $20.26 General
Category: Oncology
07/08/2019 Astellas Pharma US Inc XTANDI (Drug) Food and Beverage In-kind items and services $18.26 General
Category: ONCOLOGY
06/28/2019 Novartis Pharmaceuticals Corporation PIQRAY (Drug), SANDOSTATIN, VOTRIENT Food and Beverage In-kind items and services $14.76 General
Category: ONCOLOGY
06/26/2019 TESARO, Inc. ZEJULA (Drug) Food and Beverage In-kind items and services $15.75 General
Category: ONCOLOGY
06/26/2019 Amgen Inc. Neulasta (Biological), Vectibix Food and Beverage In-kind items and services $14.40 General
Category: Oncology
06/24/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $25.76 General
Category: RESPIRATORY
06/24/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $13.68 General
Category: ONCOLOGY
06/21/2019 AbbVie, Inc. Venclexta (Drug) Food and Beverage In-kind items and services $15.22 General
Category: Virology
06/20/2019 AMAG Pharmaceuticals, Inc. FERAHEME (Drug) Education In-kind items and services $23.97 General
Category: PARENTERAL IRON REPLACEMENT
06/06/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $7.83 General
Category: ONCOLOGY
06/01/2019 Genentech USA, Inc. Food and Beverage In-kind items and services $56.13 General
05/30/2019 Pharmacyclics LLC, An AbbVie Company Imbruvica (Drug) Food and Beverage In-kind items and services $17.82 General
Category: Oncology
05/29/2019 Merck Sharp & Dohme Corporation EMEND (Drug), KEYTRUDA, LYNPARZA Food and Beverage In-kind items and services $17.10 General
Category: ONCOLOGY
05/23/2019 Celgene Corporation Abraxane (Drug) Food and Beverage In-kind items and services $22.61 General
Category: Oncology
05/21/2019 Bayer HealthCare Pharmaceuticals Inc. Vitrakvi (Drug) Food and Beverage In-kind items and services $21.47 General
Category: Oncology
05/16/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological), LENVIMA Food and Beverage In-kind items and services $17.45 General
Category: ONCOLOGY
05/14/2019 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $15.28 General
Category: Oncology
05/13/2019 Amgen Inc. Neulasta (Biological), Vectibix Food and Beverage In-kind items and services $17.65 General
Category: Oncology
05/06/2019 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $17.46 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/05/2019 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $17.18 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 12 22 $5,852 $1,272
Total Patients
12
Total Services
22
Medicare Billing
$1,272
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 12 22 $5,852 $1,272 21.7%

About Dr. Nicole Quenelle, M.D

Dr. Nicole Quenelle, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2013. The National Provider Identifier (NPI) number assigned to this provider is 1407295983.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicole Quenelle, M.D has received a total of $5,454 in payments from pharmaceutical and medical device companies, with $149.46 received in 2023. These payments were reported across 278 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,255).

As a Medicare-enrolled provider, Quenelle has provided services to 12 Medicare beneficiaries, totaling 22 services with total Medicare billing of $1,272. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.

Practice Information

Products in Payments

  • KEYTRUDA (Biological) $483.40
  • OPDIVO (Biological) $446.43
  • IMFINZI (Drug) $227.70
  • TAGRISSO (Drug) $212.22
  • ADCETRIS (Biological) $211.71
  • JAKAFI (Drug) $211.54
  • Neulasta (Biological) $185.79
  • Abraxane (Drug) $183.18
  • Venclexta (Drug) $168.99
  • JADENU (Drug) $147.88
  • IBRANCE (Drug) $141.68
  • Kyprolis (Biological) $120.95
  • FOUNDATIONONE (Device) $118.09
  • TASIGNA (Drug) $105.45
  • Cabometyx (Drug) $95.69
  • Revlimid (Drug) $93.59
  • Erleada (Drug) $91.03
  • BOSULIF (Drug) $86.49
  • XOSPATA (Drug) $79.69
  • TECENTRIQ (Biological) $71.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in La Jolla